首站-论文投稿智能助手
典型文献
Natural product-based screening led to the discovery of a novel PXR agonist with anti-cholestasis activity
文献摘要:
Cholestasis is a major cause of a series of bile flow malfunction-related liver diseases.Pregnane X receptor(PXR)is a key regulator in endo-and xeno-biotics metabolism,which has been considered as a promising therapeutic target for cholestasis.In this study we conducted human PXR(hPXR)agonistic screening using dual-luciferase reporter gene assays,which led to discovering a series of potent hPXR agonists from a small Euphorbiaceae diterpenoid library,containing 35 structurally diverse diterpenoids with eight different skeleton types.The most active compound 6,a lathyrane diterpenoid(5/11/3 ring system),dose-dependently activated hPXR with a high selectivity,and significantly upregulated the expression of hPXR downstream genes CYP3A4 and UGT1A1.In LCA-induced cholestasis mouse model,administration of compound 6(50 mg kg-1.d-1,ip)for 7 days significantly suppressed liver necrosis and decreased serum levels of AST,ALT,Tbili,ALP,and TBA,ameliorating LCA-induced cholestatic liver injury.We further revealed that compound 6 exerted its anti-cholestatic efficacy via activation of PXR pathway,accelerating the detoxification of toxic BAs and promoting liver regeneration.These results suggest that lathyrane diterpenoids may serve as a promising scaffold for future development of anti-cholestasis drugs.
文献关键词:
作者姓名:
Dong Huang;Ying-yuan Zhao;Rui-min Wang;Wei Li;Fang-yu Yuan;Xue-long Yan;Xiao Yang;Gui-hua Tang;Sheng Yin;Hui-chang Bi
作者机构:
Guangdong Provincial Key Laboratory of New Drug Design and Evaluation,School of Pharmaceutical Sciences,Sun Yat-sen University,Guangzhou 510006,China;NMPA Key Laboratory for Research and Evaluation of Drug Metabolism,School of Pharmaceutical Sciences,Southern Medical University,Guangzhou 510515,China
引用格式:
[1]Dong Huang;Ying-yuan Zhao;Rui-min Wang;Wei Li;Fang-yu Yuan;Xue-long Yan;Xiao Yang;Gui-hua Tang;Sheng Yin;Hui-chang Bi-.Natural product-based screening led to the discovery of a novel PXR agonist with anti-cholestasis activity)[J].中国药理学报(英文版),2022(08):2139-2146
A类:
Cholestasis,Pregnane,hPXR,agonistic,lathyrane,Tbili
B类:
Natural,product,screening,discovery,novel,anti,cholestasis,activity,major,cause,series,bile,flow,malfunction,related,liver,diseases,receptor,key,regulator,endo,xeno,biotics,metabolism,which,has,been,considered,promising,therapeutic,target,In,this,study,we,conducted,human,using,dual,luciferase,reporter,assays,discovering,potent,agonists,from,small,Euphorbiaceae,library,containing,structurally,diverse,diterpenoids,eight,different,skeleton,types,most,active,compound,system,dose,dependently,activated,high,selectivity,significantly,upregulated,expression,downstream,genes,CYP3A4,UGT1A1,LCA,induced,mouse,model,administration,ip,days,suppressed,necrosis,decreased,serum,levels,AST,ALT,ALP,TBA,ameliorating,cholestatic,injury,We,further,revealed,that,exerted,its,efficacy,via,activation,pathway,accelerating,detoxification,toxic,BAs,promoting,regeneration,These,results,suggest,may,serve,scaffold,future,development,drugs
AB值:
0.614797
相似文献
Romidepsin (FK228) improves the survival of allogeneic skin grafts through downregulating the production of donor-specific antibody via suppressing the IRE1 α-XBP1 pathway
Yuliang GUO;Siyu SONG;Xiaoxiao DU;Li TIAN;Man ZHANG;Hongmin ZHOU;Zhonghua Klaus CHEN;Sheng CHANG-Institute of Organ Transplantation,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;Key Laboratory of Organ Transplantation,Ministry of Education,NHC Key Laboratory of Organ Transplantation,Key Laboratory of Organ Transplantation,Chinese Academy of Medical Sciences,Wuhan 430030,China;Henan Key Laboratory of Digestive Organ Transplantation,Open and Key Laboratory of Hepatobiliary&Pancreatic Surgery and Digestive Organ Transplantation at Henan Universities,Zhengzhou Key Laboratory of Hepatobiliary&Pancreatic Diseases and Organ Transplantation,Department of Hepatobiliary and Pancreatic Surgery,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;Department of Cardiothoracic and Vascular Surgery,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China
CircRNA.0007127 triggers apoptosis through the miR-513a-5p/CASP8 axis in K-562 cells
Xiajing LI;Yiyu ZHANG;Ning WANG;Zhaohu YUAN;Xiaojie CHEN;Qicong CHEN;Hui DENG;Xinxin TONG;Honglin CHEN;Yuyou DUAN;Yarning WEI-School of Medicine,South China University of Technology,Guangzhou 510000,China;Department of Blood Transfusion,Shenzhen Longhua Central Hospital,Shenzhen 518000,China;Laboratory of Stem Cells and Translational Medicine,Institutes for Life Sciences,School of Medicine,South China University of Technology,Guangzhou 510000,China;School of Biomedical Sciences and Engineering,Guangzhou International Campus,South China University of Technology,Guangzhou 510000,China;Department of Blood Transfusion,the Second Affiliation Hospital of South China University of Technology,Guangzhou 510000,China;Guangdong Engineering Research Center of Precise Transfusion,Guangzhou 510000,China
Overexpressed NEDD8 as a potential therapeutic target in esophageal squamous cell carcinoma
Jingrong Xian;Shiwen Wang;Yanyu Jiang;Lihui Li;Lili Cai;Ping Chen;Yue Liu;Xiaofei Zeng;Guoan Chen;Chen Ding;Robert M.Hoffman;Lijun Jia;Hu Zhao;Yanmei Zhang-Department of Laboratory Medicine,Huadong Hospital Affiliated to Fudan University,Shanghai 200040,China;Cancer Institute,Longhua Hospital,Shanghai University of Traditional Chinese Medicine,Shanghai 200032,China;Research Center on Aging and Medicine,Fudan University,Shanghai 200040,China;Shanghai Key Laboratory of Clinical Geriatric Medicine,Shanghai 200040,China;Department of Basic Science of Oncology,College of Basic Medical Sciences,Zhengzhou University,Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;School of Medicine,Southern University of Science and Technology,Shenzhen 518055,China;State Key Laboratory of Genetic Engineering,Human Phenome Institute,Institutes of Biomedical Sciences,School of Life Sciences,Zhongshan Hospital,Fudan University,Shanghai 200032,China;State Key Laboratory of Cell Differentiation and Regulation,Henan International Joint Laboratory of Pulmonary Fibrosis,Henan Center for Outstanding Overseas Scientists of Pulmonary Fibrosis,College of Life Science,Institute of Biomedical Science,Henan Normal University,Xinxiang 453007,China;Department of Surgery,University of California,San Diego 92101,USA;Anticancer Inc.,San Diego 92101,USA
Paired box 5 increases the chemosensitivity of esophageal squamous cell cancer cells by promoting p53 signaling activity
Zhang Weiwei;Yan Wenji;Qian Niansong;Han Quanli;Zhang Weitao;Dai Guanghai-Chinese People’s Liberation Army Medical School, Beijing 100853, China;Department of the Third Health Care, The Second Medical Center, Chinese People’s Liberation Army General Hospital, Beijing 100853, China;Department of Oncology, The First Medical Center, Chinese People’s Liberation Army General Hospital, Beijing 100853, China;Department of Oncology, The Hainan Medical Center, Chinese People’s Liberation Army General Hospital, Sanya 572022, China;Cancer Center, Beijing Tongren Hospital Affiliated to Capital Medical University, Economic and Technological Development Zone, Beijing 100176, China
Macrophage polarization is involved in liver fibrosis induced by β1-adrenoceptor autoantibody
Ye Wu;Xiongxiong Fan;Haicun Yu;Jingyi Liu;Yanru Duan;Suli Zhang;Li Yan;Yunhui Du;Huirong Liu-Department of Physiology and Pathophysiology,School of Basic Medical Sciences,Capital Medical University,Beijing 100069,China;Beijing key laboratory of metabolic disorder related cardiovascular disease,School of Basic Medical Sciences,Capital Medical University,Beijing 100069,China;Zhengzhou Central Hospital affiliated of Zhengzhou University,Zhengzhou 450000,China;Shanxi Cardiovascular Hospital,Cardiac Care Unit,Taiyuan 030024,China;Department of Pathophysiology,Institute of Basic Medical Science,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing 100005,China;Beijing Anzhen Hospital,Capital Medical University,Beijing Institute of Heart,Lung and Blood Vessel Diseases,Beijing100029,China
A novel PI3K inhibitor XH30 suppresses orthotopic glioblastoma and brain metastasis in mice models
Ming Ji;Dongjie Wang;Songwen Lin;Chunyang Wang;Ling Li;Zhihui Zhang;Jing Jin;Deyu Wu;Yi Dong;Heng Xu;Duo Lu;Xiaoguang Chen-State Key Laboratory of Bioactive Substances and Functions of Natural Medicines,Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China;Beijing Key Laboratory of Non-Clinical Drug Metabolism and PK/PD Study,Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China;Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study,Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China
Therapeutic potential of traditional Chinese medicine for the treatment of NAFLD:A promising drug Potentilla discolor Bunge
Longshan Ji;Qian Li;Yong He;Xin Zhang;Zhenhua Zhou;Yating Gao;Miao Fang;Zhuo Yu;Robim M.Rodrigues;Yueqiu Gao;Man Li-Laboratory of Cellular Immunity,Institute of Clinical Immunology,Shanghai Key Laboratory of Traditional Chinese Medicine,Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Key Laboratory of Liver and Kidney Diseases(Shanghai University of Traditional Chinese Medicine),Ministry of Education,Shanghai 201203,China;Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;Department of Hepatopathy,Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China;Department of in Vitro Toxicology and Dermato-Cosmetology,Faculty of Medicine and Pharmacy,Vrije Universiteit Brussel,Brussels 1000,Belgium
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。